Table 5.
Use of cardiovascular drugs by elderly patients with hypertension according to ACE I/D genotypes (II vs ID/DD)
| Variables | II | ID/DD | P value |
|---|---|---|---|
| No. (%) | No. (%) | ||
| No. of used cardiovascular drugs | |||
| 0 | 4 (15.4) | 10 (10.5) | .721 |
| 1 | 12 (46.2) | 36 (37.9) | |
| 2 | 7 (26.9) | 34 (35.8) | |
| 3 | 3 (11.5) | 12 (12.6) | |
| 4 | 0 (0.0) | 3 (3.2) | |
| Thiazide diuretics | |||
| Yes | 5 (19.2) | 32 (33.7) | .156 |
| No | 21 (80.8) | 63 (66.3) | |
| Loop diuretics | |||
| Yes | 1 (3.8) | 11 (11.6) | .458 |
| No | 25 (96.2) | 84 (88.4) | |
| Potassium‐sparing diuretics | |||
| Yes | 0 (0.0) | 6 (6.3) | .339 |
| No | 26 (100.0) | 89 (93.7) | |
| ACE inhibitors | |||
| Yes | 7 (26.9) | 26 (27.4) | .964 |
| No | 19 (73.1) | 69 (72.6) | |
| β‐Blockers | |||
| Yes | 6 (23.1) | 21 (22.1) | .919 |
| No | 20 (76.9) | 74 (77.9) | |
| ATR1 blockers | |||
| Yes | 9 (34.6) | 34 (35.8) | .912 |
| No | 17 (65.4) | 61 (64.2) | |
| Calcium channel blockers | |||
| Yes | 6 (23.1) | 20 (21.7) | .884 |
| No | 20 (76.9) | 72 (78.3) | |
ACE, angiotensin‐converting enzyme; ATR1, angiotensin II type 1 receptor; D, deletion, I, insertion.
Data from Aiquara, Bahia, Brazil (2015).